Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam bought 663 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were acquired at an average price of GBX 49 ($0.65) per share, for a total transaction of £324.87 ($431.95).
Jayne Cottam also recently made the following trade(s):
- On Tuesday, July 22nd, Jayne Cottam sold 94,230 shares of Assura stock. The shares were sold at an average price of GBX 50 ($0.66), for a total transaction of £47,115 ($62,644.60).
- On Wednesday, July 9th, Jayne Cottam bought 607 shares of Assura stock. The shares were acquired at an average price of GBX 50 ($0.66) per share, for a total transaction of £303.50 ($403.54).
Assura Price Performance
Shares of Assura stock traded down GBX 0.12 ($0.00) during trading on Wednesday, hitting GBX 49.10 ($0.65). 36,925,203 shares of the company's stock traded hands, compared to its average volume of 28,466,516. The company has a market cap of £1.60 billion, a PE ratio of -46.93, a PEG ratio of 3.60 and a beta of 0.37. The firm's fifty day moving average price is GBX 49.88 and its 200 day moving average price is GBX 46.43. Assura Plc has a twelve month low of GBX 35.24 ($0.47) and a twelve month high of GBX 50.95 ($0.68). The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84.
Assura (LON:AGR - Get Free Report) last issued its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. Analysts forecast that Assura Plc will post 3.5830389 earnings per share for the current year.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.